Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

Enhanced safety surveillance (ESS) was conducted in the United Kingdom and Finland for Vaxigrip and Intanza 15 µg to comply with the European Medicines Agency interim guidance aimed to detect any potential increase in reactogenicity in near real time following the annual update of the influenza vacc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Euro Surveill
Hoofdauteurs: Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: European Centre for Disease Prevention and Control (ECDC) 2017
Onderwerpen:
Surveillance and Outbreak Report
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5434878/
https://ncbi.nlm.nih.gov/pubmed/28494843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2807/1560-7917.ES.2017.22.18.30527
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items